Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics“ATNM-400 is...
FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer“Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte study. First...
Duke researchers discover new origin of small cell lung cancer in study“DURHAM, N.C. (WTVD) — Small cell lung cancer is one of the most aggressive and deadly forms of lung cancer commonly associated with smoking. Now, researchers at Duke Health have uncovered a...
WCLC 2025: The Top 5 Takeaways Across Lung Cancer Care“CancerNetwork® covered the newest clinical trial findings that researchers presented at the meeting. Here are the top 5 takeaways that may impact lung cancer management.” Impact of Anticoagulant and Antiplatelet...
New Summit data clouds approval pathway in lung cancer“A combination of ivonescimab and chemotherapy didn’t extend survival over chemo alone in a global trial, missing a key goal often emphasized by regulators.” First-in-human trial shows promising results for...
The quality of patient decision aids for lung cancer screening: Results from an environmental scan“Shared decision making is recommended for lung cancer screening (LCS) by professional organizations and payers. Patient decision aids can be used to support shared...
More News and Updates